Trump Administration Weighs Marijuana Rescheduling as Lawmaker Reintroduces Bill

President Donald Trump confirmed Monday that his administration is weighing whether to reclassify marijuana as a less dangerous drug, potentially reducing criminal penalties and providing significant tax relief to cannabis companies.

Speaking during a White House press conference, Trump said the administration will “make a determination over, I’d say, the next few weeks” on whether to move marijuana from Schedule I to Schedule III under the Controlled Substances Act.

Rep. Greg Steube, R-Fla., announced this week he is reintroducing his Marijuana 1-to-3 Act, which would accomplish the same reclassification through congressional action. Steube called the current system illogical, noting that marijuana is classified alongside heroin and LSD while cocaine receives a less restrictive Schedule II designation.

“This is a common-sense change that will finally allow real scientific research into its medicinal value,” Steube said, urging the Trump administration to support the effort.

Under federal law, marijuana is currently a Schedule I substance, defined as having “no currently accepted medical use and a high potential for abuse.” Schedule III drugs, by contrast, are considered to have “moderate to low risk of physical or psychological dependence” and include ketamine, anabolic steroids and certain prescription medications.

Related: Is Trump Moving Forward with Marijuana Rescheduling? 

The reclassification would not make marijuana federally legal for recreational use, but would significantly benefit the cannabis industry. Companies would no longer be subject to Section 280E of the federal tax code, which prevents businesses dealing with Schedule I and II controlled substances from claiming standard business deductions.

The push comes after cannabis industry executives attended a $1 million-per-plate fundraiser at Trump’s New Jersey golf club earlier this month, where they discussed potential policy changes with the president. 

Related: DEA Nominee Views Cannabis Reclassification as Priority, Stops Short of Guarantee

Tilray CEO Irwin Simon told CNBC he expects the reclassification process to take about a year if implemented. “Trump gets things done,” Simon said. “He wouldn’t be talking about it if he’s not going to get something done.”



Information for this story was found via the sources and companies mentioned. The author has no securities or affiliations related to the organizations discussed. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Video Articles

Why the Market May Be Misreading Iran | David Woo

Why US Fertilizer Supply Could Matter a Lot More Now | Pat Varas – Sage Potash

Roscan Gold: Mali Discount Hits Kandiole PEA

Recommended

Canadian Gold Drills 19.5 g/t Gold Over 1.0 Metre At Lac Arsenault

Canadian Copper Secures Key Approval for Caribou Complex Acquisition

Related News

Trump DOJ Defends Biden EPA Pebble Veto

Northern Dynasty Minerals sold off sharply after the DOJ filed an opposition brief defending the...

Thursday, February 19, 2026, 10:06:00 AM

Do the “Drill, Baby, Drill” Economics Make Sense at $50 per Barrel?

Industry experts are challenging US Energy Secretary Chris Wright’s claim that shale producers can profitably...

Tuesday, March 11, 2025, 12:52:00 PM

Economists Question Trump’s $10 Trillion Investment Claims

President Donald Trump’s claims of securing more than $10 trillion in new US investment commitments...

Monday, June 9, 2025, 12:59:00 PM

SEC Prioritizes Trump’s Push to End Quarterly Earnings Reports

The Securities and Exchange Commission said Monday it is “prioritizing” President Donald Trump’s proposal to...

Tuesday, September 16, 2025, 08:39:38 AM

US Military Strikes Drug Vessel from Venezuela, Killing 11

US military forces conducted a deadly strike Tuesday against a suspected drug smuggling vessel in...

Wednesday, September 3, 2025, 03:29:00 PM